250 related articles for article (PubMed ID: 31136288)
1. Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage.
You S; Zheng D; Delcourt C; Sato S; Cao Y; Zhang S; Yang J; Wang X; Lindley RI; Robinson T; Anderson CS; Chalmers J
Stroke; 2019 Jun; 50(6):1409-1414. PubMed ID: 31136288
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of perihematomal edema in acute intracerebral hemorrhage: pooled analysis from the intensive blood pressure reduction in acute cerebral hemorrhage trial studies.
Yang J; Arima H; Wu G; Heeley E; Delcourt C; Zhou J; Chen G; Wang X; Zhang S; Yu S; Chalmers J; Anderson CS;
Stroke; 2015 Apr; 46(4):1009-13. PubMed ID: 25712944
[TBL] [Abstract][Full Text] [Related]
3. Subarachnoid extension of intracerebral hemorrhage and 90-day outcomes in INTERACT2.
Chen G; Arima H; Wu G; Heeley E; Delcourt C; Zhang P; Rabinstein AA; Robinson T; Stapf C; Huang Y; Song L; Yang J; Wang X; Li Q; Chen X; Chalmers J; Anderson C;
Stroke; 2014 Jan; 45(1):258-60. PubMed ID: 24149007
[TBL] [Abstract][Full Text] [Related]
4. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT).
Anderson CS; Huang Y; Arima H; Heeley E; Skulina C; Parsons MW; Peng B; Li Q; Su S; Tao QL; Li YC; Jiang JD; Tai LW; Zhang JL; Xu E; Cheng Y; Morgenstern LB; Chalmers J; Wang JG;
Stroke; 2010 Feb; 41(2):307-12. PubMed ID: 20044534
[TBL] [Abstract][Full Text] [Related]
5. Significance of intraventricular hemorrhage in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial results.
Chan E; Anderson CS; Wang X; Arima H; Saxena A; Moullaali TJ; Heeley E; Delcourt C; Wu G; Wang J; Chen G; Lavados PM; Stapf C; Robinson T; Chalmers J; Huang Y;
Stroke; 2015 Mar; 46(3):653-8. PubMed ID: 25677598
[TBL] [Abstract][Full Text] [Related]
6. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study.
Qureshi AI; Palesch YY; Martin R; Novitzke J; Cruz-Flores S; Ehtisham A; Ezzeddine MA; Goldstein JN; Hussein HM; Suri MF; Tariq N;
Arch Neurol; 2010 May; 67(5):570-6. PubMed ID: 20457956
[TBL] [Abstract][Full Text] [Related]
7. Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results.
Carcel C; Wang X; Sato S; Stapf C; Sandset EC; Delcourt C; Arima H; Robinson T; Lavados P; Chalmers J; Anderson CS;
Stroke; 2016 Jun; 47(6):1651-3. PubMed ID: 27143274
[TBL] [Abstract][Full Text] [Related]
8. White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial.
Yu S; Arima H; Heeley E; Delcourt C; Krause M; Peng B; Yang J; Wu G; Chen X; Chalmers J; Anderson CS;
J Neurol Sci; 2016 Feb; 361():112-6. PubMed ID: 26810526
[TBL] [Abstract][Full Text] [Related]
9. Mannitol and Outcome in Intracerebral Hemorrhage: Propensity Score and Multivariable Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Results.
Wang X; Arima H; Yang J; Zhang S; Wu G; Woodward M; Muñoz-Venturelli P; Lavados PM; Stapf C; Robinson T; Heeley E; Delcourt C; Lindley RI; Parsons M; Chalmers J; Anderson CS;
Stroke; 2015 Oct; 46(10):2762-7. PubMed ID: 26265125
[TBL] [Abstract][Full Text] [Related]
10. Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies.
Qiu M; Sato S; Zheng D; Wang X; Carcel C; Hirakawa Y; Sandset EC; Delcourt C; Arima H; Wang J; Chalmers J; Anderson CS;
Stroke; 2016 Jun; 47(6):1479-85. PubMed ID: 27165954
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.
Wang X; Arima H; Heeley E; Delcourt C; Huang Y; Wang J; Stapf C; Robinson T; Woodward M; Chalmers J; Anderson CS;
Hypertension; 2015 May; 65(5):1026-32. PubMed ID: 25801872
[TBL] [Abstract][Full Text] [Related]
12. Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage Study.
Yamaguchi Y; Koga M; Sato S; Yamagami H; Todo K; Okuda S; Okada Y; Kimura K; Shiokawa Y; Kamiyama K; Itabashi R; Hasegawa Y; Kario K; Fujita K; Kumamoto M; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yoshimura S; Nagatsuka K; Toyoda K;
Cerebrovasc Dis; 2018; 46(3-4):118-124. PubMed ID: 30199854
[TBL] [Abstract][Full Text] [Related]
13. Optimum Baseline Clinical Severity Scale Cut Points for Prognosticating Intracerebral Hemorrhage: INTERACT Studies.
You S; Zheng D; Yoshimura S; Ouyang M; Han Q; Wang X; Cao Y; Delcourt C; Song L; Arima H; Chen X; Liu CF; Lindley RI; Robinson T; Anderson CS; Chalmers J;
Stroke; 2024 Jan; 55(1):139-145. PubMed ID: 38018833
[TBL] [Abstract][Full Text] [Related]
14. Significance of Hematoma Shape and Density in Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial Study.
Delcourt C; Zhang S; Arima H; Sato S; Al-Shahi Salman R; Wang X; Davies L; Stapf C; Robinson T; Lavados PM; Chalmers J; Heeley E; Liu M; Lindley RI; Anderson CS;
Stroke; 2016 May; 47(5):1227-32. PubMed ID: 27073236
[TBL] [Abstract][Full Text] [Related]
15. Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.
Jusufovic M; Berge TE; Guo R; You S; Delcourt C; Anderson C; Bath PM; Karlson BW; Berge E; Sandset EC;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2262-2267. PubMed ID: 31178359
[TBL] [Abstract][Full Text] [Related]
16. Predictors and Outcomes of Neurological Deterioration in Intracerebral Hemorrhage: Results from the TICH-2 Randomized Controlled Trial.
Law ZK; Dineen R; England TJ; Cala L; Mistri AK; Appleton JP; Ozturk S; Bereczki D; Ciccone A; Bath PM; Sprigg N;
Transl Stroke Res; 2021 Apr; 12(2):275-283. PubMed ID: 32902808
[TBL] [Abstract][Full Text] [Related]
17. No relationship of lipid-lowering agents to hematoma growth: pooled analysis of the intensive blood pressure reduction in acute cerebral hemorrhage trials studies.
Priglinger M; Arima H; Anderson C; Krause M;
Stroke; 2015 Mar; 46(3):857-9. PubMed ID: 25657175
[TBL] [Abstract][Full Text] [Related]
18. Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study.
Delcourt C; Huang Y; Arima H; Chalmers J; Davis SM; Heeley EL; Wang J; Parsons MW; Liu G; Anderson CS;
Neurology; 2012 Jul; 79(4):314-9. PubMed ID: 22744655
[TBL] [Abstract][Full Text] [Related]
19. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial.
Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI
Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage.
Wang X; Sandset EC; Moullaali TJ; Chen G; Song L; Carcel C; Delcourt C; Woodward M; Robinson T; Chalmers J; Arima H; Anderson CS;
J Hypertens; 2019 Jul; 37(7):1463-1466. PubMed ID: 31085948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
